The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Giulia Marchetti
Dept of Medicine
Surgery and Dentistry- Clinic of Infectious Diseases - "San Paolo" Hospital - University of Milan via A. di Rudinì
8 - 20142 Milan
Italy
Name/email consistency: high
- Immune Reconstitution in HIV+ Subjects on Lopinavir/Ritonavir-Based HAART According to the Severity of Pre-Therapy CD4+. Marchetti, G., Merlini, E., Sinigaglia, E., Iannotti, N., Bai, F., Savoldi, A., Tincati, C., Carpani, G., Bini, T., Arminio Monforte, A. Curr. HIV Res. (2012)
- Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. Marchetti, G., Cozzi-Lepri, A., Merlini, E., Bellistrì, G.M., Castagna, A., Galli, M., Verucchi, G., Antinori, A., Costantini, A., Giacometti, A., di Caro, A., D'arminio Monforte, A. AIDS (2011)
- Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART. Marchetti, G., Gazzola, L., Trabattoni, D., Bai, F., Ancona, G., Ferraris, L., Meroni, L., Galli, M., Clerici, M., Gori, A., D'Arminio Monforte, A. AIDS (2010)
- HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis. Marchetti, G., Riva, A., Cesari, M., Bellistrì, G.M., Gianelli, E., Casabianca, A., Orlandi, C., Magnani, M., Meroni, L., d'Arminio Monforte, A., Mussini, C., Cossarizza, A., Galli, M., Gori, A. HIV Med. (2009)
- Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. Marchetti, G., Bellistrì, G.M., Borghi, E., Tincati, C., Ferramosca, S., La Francesca, M., Morace, G., Gori, A., Monforte, A.D. AIDS (2008)
- The challenge of IL-2 immunotherapy in HIV disease: "no through road" or turning point? Marchetti, G., Tincati, C., Monforte, A., Gori, A. Curr. HIV Res. (2008)
- Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. Marchetti, G., Gori, A., Casabianca, A., Magnani, M., Franzetti, F., Clerici, M., Perno, C.F., Monforte, A., Galli, M., Meroni, L. AIDS (2006)
- Partial immune reconstitution following highly active antiretroviral therapy: can adjuvant interleukin-2 fill the gap?. Marchetti, G., Franzetti, F., Gori, A. J. Antimicrob. Chemother. (2005)
- IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients. Marchetti, G., Meroni, L., Molteni, C., Taskaris, G., Gazzola, L., Galli, M., Clerici, M., Moroni, M., Franzetti, F., Gori, A. Antivir. Ther. (Lond.) (2004)
- Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment. Marchetti, G., Meroni, L., Varchetta, S., Terzieva, V., Bandera, A., Manganaro, D., Molteni, C., Trabattoni, D., Fossati, S., Clerici, M., Galli, M., Moroni, M., Franzetti, F., Gori, A. J. Infect. Dis. (2002)
